1 / 1

CK8

N-Cadherin. Fibronectin. Twist. CK8. CK14. CK17. CK18. CK19. CK5. CK6. Vimentin. CK20. EpCAM. Muc1. EGFR. panCTC. panCK. CK19. Supplementary Figure 1. B. A. C. D.

tate
Download Presentation

CK8

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. N-Cadherin Fibronectin Twist CK8 CK14 CK17 CK18 CK19 CK5 CK6 Vimentin CK20 EpCAM Muc1 EGFR panCTC panCK CK19 Supplementary Figure 1. B A C D Supplemental Figure 1. Marker development for CTC and blood cells.(A) MDA-MB-468 cells were spiked into PBMC and hybridized with probes to detect epithelial cell marker mRNAs including CK8, CK14, CK17, CK18, CK19, CK20, EpCAM, Muc1, and EGFR. (B) MRC-5 cells were spiked into PBMC and hybridized with probes to detect EMT marker mRNAs, including Twist, N-Cadherin, and Fibronectin. (C) PBMCs showing epithelial or EMT marker mRNAs, including CK5, CK6, and Vimentin. (D) MDA-MB-468 cells were spiked into PBMC and hybridized with a probes to detect CK19 mRNA , CK8, 18, and 19 mRNAs (panCK), or CK8, CK14, CK17, CK18, CK19, CK20, EpCAM, Muc1, EGFR, Twist, N-Cadherin, and Fibronectin mRNAs (panCTC). Cells were counterstained with DAPI (blue).

More Related